Eddy A A, Kim H, López-Guisa J, Oda T, Soloway P D
The Children's Hospital and Regional Medical Center, University of Washington, Seattle 98105, USA.
Kidney Int. 2000 Aug;58(2):618-28. doi: 10.1046/j.1523-1755.2000.00208.x.
Progressive renal interstitial fibrosis is characterized by up-regulated expression of the gene that encodes the tissue inhibitor of metalloproteinases-1 (TIMP-1), a regulator of extracellular matrix remodeling, suggesting that impaired matrix turnover contributes to the fibrogenic process. The present study was designed to develop a murine model of renal interstitial fibrosis, and to determine the functional significance of up-regulated Timp-1 expression by comparing the severity of this renal disease in wild-type mice and mice genetically deficient in Timp-1.
Initial pilot studies developed and characterized a murine model of bovine serum albumin (BSA)-induced protein-overload proteinuria with respect to the degree of proteinuria, severity of interstitial fibrosis, and renal mRNA levels for genes encoding matrix proteins, transforming growth factor-beta1 (TGF-beta1), and TIMP-1, -2, -3, and -4. In the final study, the severity of interstitial fibrosis was compared in wild-type and Timp-1-deficient mice after six weeks of proteinuria.
Mice injected with large daily intraperitoneal doses of BSA developed proteinuria, interstitial inflammation, and progressive interstitial fibrosis. A time course study based on measurements after one, two, and six weeks of BSA injections showed increased renal mRNA levels for the matrix genes procollagens alpha1(I), alpha1(III), and alpha2(IV) and TGF-beta1 and Timp-1. Timp-2 and Timp-3 genes were constitutively expressed at high levels in the normal kidneys and showed little change in the proteinuric kidneys. Timp-4 transcripts were not detected in any of the kidneys. After six weeks of BSA overload-proteinuria, the groups (N = 8 per group) of wild-type and Timp-1-deficient mice developed significant interstitial fibrosis compared with the control saline-injected groups. The severity of the interstitial fibrosis was similar in both proteinuric groups based on an assessment of the final kidney weight, total kidney collagen content, and the number of interstitial fields with increased fibronectin staining.
Results of the present study indicate that TIMP-1 deficiency does not alter the degree of interstitial fibrosis in the murine overload proteinuria model. Potential explanations include Timp-1 genetic redundancy, as suggested by the observation that, despite significant intrarenal induction of the Timp-1 gene expression, net renal metalloproteinase-9 (MMP-9) activity was not significantly altered. TIMP-1 is a multifunctional protein that may play a metalloproteinase-independent role in response to renal injury.
进行性肾间质纤维化的特征是编码金属蛋白酶组织抑制剂-1(TIMP-1)的基因表达上调,TIMP-1是细胞外基质重塑的调节剂,这表明基质转换受损促成了纤维化过程。本研究旨在建立一种肾间质纤维化的小鼠模型,并通过比较野生型小鼠和Timp-1基因缺陷小鼠的这种肾脏疾病严重程度,来确定Timp-1表达上调的功能意义。
初步的先导研究建立并描述了一种牛血清白蛋白(BSA)诱导的蛋白尿过载小鼠模型,涉及蛋白尿程度、间质纤维化严重程度以及编码基质蛋白、转化生长因子-β1(TGF-β1)和TIMP-1、-2、-3和-4的基因的肾mRNA水平。在最终研究中,比较了蛋白尿六周后野生型和Timp-1缺陷小鼠的间质纤维化严重程度。
每天腹腔注射大剂量BSA的小鼠出现蛋白尿、间质炎症和进行性间质纤维化。基于BSA注射1周、2周和6周后的测量进行的时间进程研究显示,基质基因原胶原α1(I)、α1(III)和α2(IV)以及TGF-β1和Timp-1的肾mRNA水平升高。Timp-2和Timp-3基因在正常肾脏中持续高水平表达,在蛋白尿肾脏中变化不大。在任何肾脏中均未检测到Timp-4转录本。BSA过载蛋白尿六周后,野生型和Timp-1缺陷小鼠组(每组N = 8)与注射生理盐水的对照组相比,出现了明显的间质纤维化。根据最终肾脏重量、肾脏总胶原含量以及纤连蛋白染色增加的间质区域数量评估,两个蛋白尿组的间质纤维化严重程度相似。
本研究结果表明,在小鼠蛋白尿过载模型中,TIMP-1缺陷不会改变间质纤维化程度。可能的解释包括Timp-1基因冗余,这从以下观察结果可以看出,尽管Timp-1基因表达在肾内显著诱导,但肾金属蛋白酶-9(MMP-9)的净活性并未显著改变。TIMP-1是一种多功能蛋白,在应对肾损伤时可能发挥与金属蛋白酶无关的作用。